Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TECX
TECTONIC THERAPEUTIC, INC.
NASDAQ
$35.62
▼ DOWN 2.94% (-1.08)

KEY STATISTICS

Market Cap$672.12 M
52w High$39.53
52w Low$14.39
Dividend Yield—
Frequency—
P/E-7.99
Volume157.79K
Shares Out.18.87M

COMPANY

LEADERSHIP

Alise S. Reicin
CHIEF EXECUTIVE
Alise S. Reicin

COMPENSATION 2026

Salary$640,833
Stock Awards$1,946,853
Incentive Plan Pay$372,500
All Other Comp.$17,775
Total$7,351,578

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 21, 2018
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
60

PRICE TARGET

Target High$81.00
Target Low$75.00
Target Median$78.00
Target Consensus$78.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.—
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2024-06-21Reverse1:12

PRICE

$35.62 ▼ DOWN 2.94% (−$1.08)
OVERLAYS
$35.10$35.40$35.70$36.009:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM35.62

About Tectonic Therapeutic, Inc.

https://tectonictx.com ↗

Tectonic Therapeutic, Inc. is a Massachusetts-based biotech developing GPCR-targeted biologics using its GEODe platform, with pipeline candidates for heart failure, hereditary hemorrhagic telangiectasia, and fibrosis.

INDUSTRY

Biotechnology

A SERVICE TECTONIC THERAPEUTIC, INC. IS KNOWN FOR

TX45

TX45, developed by Tectonic Therapeutic, is a long-acting relaxin-fusion therapy in clinical-stage for treating Group 2 pulmonary hypertension with HFpEF, showing promising early results as their lead innovative biologic candidate.

COMPETITORS

COMPETITOR
ANIP COMPARE
ARDX COMPARE
SNDX COMPARE
STOK COMPARE
VCEL COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
69
LISTED HERE
14
RANKED BY POSITION SIZE
VTS.AX
0.00% · 475.3K
XSU.TO
0.01% · 265.4K
R2SC.L
0.01% · 23.7K
SBIO
0.34% · 23.4K
AVSC
0.02% · 21.4K
BBC
0.73% · 10.4K
XRS2.F
0.01% · 9.4K
DFAS
0.00% · 8.0K
GSSC
0.02% · 7.0K
RSSL
0.01% · 4.8K
IBBQ
0.04% · 1.2K
WCEO
0.19% · 705
BIB
0.02% · 677
RESM
0.01% · 19

INSTITUTIONAL OWNERSHIP

SHARES OWNED
61.40%
HOLDERS
166
TOP 12 OF 166 · RANKED BY POSITION SIZE
Fmr LLC
2.8M sh · $97.29M
Tcg Crossover Management, LLC
1.2M sh · $41.42M
Abrdn Plc
1.1M sh · $39.25M
Braidwell LP
927.5K sh · $19.35M
Baker Bros. Advisors LP
903.4K sh · $18.84M
Blackrock, Inc.
862.6K sh · $29.65M
First Light Asset Management, LLC
800.7K sh · $27.52M
Farallon Capital Management LLC
640.0K sh · $10.04M
5am Venture Management, LLC
606.7K sh · $20.85M
Vanguard Group Inc
599.9K sh · $12.51M
Orbimed Advisors LLC
574.6K sh · $11.99M
Point72 Asset Management, L.P.
492.3K sh · $10.27M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF SCIENTIFIC OFFICER
McNamara Peter
Purchase · 43 shares
2026-08-25
★
OFFICER: CHIEF SCIENTIFIC OFFICER
McNamara Peter
Sale · 43 shares
2026-08-25
★
OFFICER: CHIEF SCIENTIFIC OFFICER
McNamara Peter
Sale · 43 shares
2026-08-12
★
OFFICER: CHIEF SCIENTIFIC OFFICER
McNamara Peter
Purchase · 43 shares
2026-08-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 1
STRONG BUY 1
BUY 1
3 GRADES IN THE LAST 12 MONTHS
Wells Fargo OVERWEIGHT Raymond James STRONG BUY Truist Securities BUY

SECTORS PEERS

PEERPRICE
DRTS$14.64COMPARE
ANRO$35.13COMPARE
SLN$13.42COMPARE
LRMR$4.01COMPARE
LYEL$14.53COMPARE
CLLS$3.40COMPARE
DBVT$13.54COMPARE
AMRN$13.97COMPARE